Long-lasting otic solution containing mometasone furoate can influence intradermal testing in dogs with healthy ears and otitis externa.

BACKGROUND: Topical therapy is preferred for otitis externa (OE) in dogs. Otic products commonly contain glucocorticoids that can be systemically absorbed and possibly interfere with diagnostic tests such as intradermal testing (IDT). HYPOTHESIS/OBJECTIVES: To determine the effect of a long-lasting otic solution containing mometasone furoate (MF) on IDT immediate reactions and to determine withdrawal time before IDT. ANIMALS: Seventeen dogs with healthy ears (Group 1) and 12 with OE (Group 2). MATERIALS AND METHODS: Intradermal injections of histamine, anticanine-immunoglobulin (Ig)E and saline were subjectively and objectively evaluated before treatment and weekly for 6 weeks, after a single application of a long-lasting otic solution containing MF. RESULTS: Statistically significant reductions in the mean subjective histamine scores after application of MF were observed at Weeks 1 (p = 0.012) and 2 (p = 0.028) in Group 1, and Weeks 1 (p = 0.00066), 2 (p = 0.02) and 4 (p = 0.034) in Group 2. Mean histamine objective scores were significantly reduced in Weeks 1 (p = 0.042), 2 (p = 0.0009), 3 (p = 0.001) and 5 (p = 0.018) in Group 1 only. The mean subjective anticanine-IgE scores were significantly reduced in Week 1 in both groups (p = 0.003, p = 0.0066), respectively. There were no significant changes in the mean anticanine-IgE objective score in either group. CONCLUSIONS AND CLINICAL RELEVANCE: Application of a long-lasting otic solution containing MF can interfere with IDT immediate reactions in healthy and OE dogs. Based on the subjective evaluation, IDT can be performed ≥2 weeks after application of the otic solution in healthy dogs, and ≥4 weeks in dogs with OE.

Dermal arteritis of the nasal philtrum: a retrospective study of 23 dogs.

BACKGROUND: Dermal arteritis of the nasal philtrum (DANP) is a cutaneous vascular condition that selectively targets large vessels of the nasal philtrum of dogs; little information is published about this disease. OBJECTIVE: The aim of this study was to report the signalment, clinical signs, treatment options and outcome of dogs with DANP, and to propose a rationale for the clinical diagnosis. ANIMALS: Twenty-three dogs from four referral veterinary clinics from January 2002 to July 2018. METHODS AND MATERIALS: Retrospective analysis of medical records of dogs with diagnosis of DANP. RESULTS: The mean age at disease onset was 5.3 years. Nineteen dogs were pure-bred (11 different breeds) and four were mixed breed. Twenty-three dogs had a clinical diagnosis of DANP and three of these had histopathological confirmation. Eight dogs had episodes of profuse arterial bleeding from the lesion, nine had minor bleeding and six no bleeding. Twenty dogs were managed medically with monotherapy or combined therapy of topical tacrolimus, prednisolone, doxycycline and niacinamide, and/or pentoxifylline. Long-term tacrolimus was prescribed for 15 cases, eight of those cases as sole therapy. Treatment was declined for three dogs and four dogs were lost to follow-up. The lesion was satisfactorily controlled in 12 dogs and well-controlled in four dogs. CONCLUSIONS AND CLINICAL IMPORTANCE: The distinctive presentation of DANP substantiates the clinical diagnosis. Medical treatment seems to be effective in controlling DANP and tacrolimus used as sole or adjunctive therapy appears to manage the disease satisfactorily.

A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA.

BACKGROUND: Lokivetmab neutralizes IL-31, a cytokine that plays an important role in the pathogenesis of atopic dermatitis (AD) in dogs. OBJECTIVE: To review experience of one year of treatment with lokivetmab for the control of pruritus in dogs with allergic dermatitis. ANIMALS: Eighty dogs diagnosed with AD, ten with concurrent adverse food reaction and AD and 45 with allergic dermatitis of undetermined cause. Three dogs were lost to follow- up. METHODS AND MATERIALS: Retrospective analysis of medical records of dogs with allergic dermatitis treated with lokivetmab from November 2015 to October 2016. Treatment success for owner-assessed pruritus was empirically defined as ≥2 cm reduction in Visual Analog Scale (pVAS) from baseline. A ≥50% reduction in pVAS also was recorded. RESULTS: Pruritus improvement was achieved in 116 of 132 dogs (87.8%) following initial lokivetmab administration at 1.8 to 3.7 mg/kg (P < 0.001). A pVAS reduction of ≥50% was recorded in 104 dogs (77.0%). Dogs with severe/very severe pruritus prior to treatment and large/giant sized dogs, had 2.7 and 2.8 times higher odds of treatment success, respectively. There were no significant associations between treatment success and age of onset of clinical signs, disease chronicity, lokivetmab dosage or age at initial lokivetmab administration. Dogs that did not previously respond to oclacitinib were less likely to respond to lokivetmab. Adverse effects including lethargy, vomiting, hyperexcitability, pain at injection site and urinary incontinence were reported in 11 of 132 dogs. CONCLUSIONS AND CLINICAL IMPORTANCE: Lokivetmab at labelled dosages was a fast, safe and efficacious therapy for the control of pruritus in dogs with allergic dermatitis.

Evaluation of immunological parameters in pit bull terrier-type dogs with juvenile onset generalized demodicosis and age-matched healthy pit bull terrier-type dogs.

BACKGROUND: Juvenile onset generalized demodicosis (JOGD) is thought to occur due to immunological abnormalities and is over-represented in pit bull terrier-type dogs. ANIMALS: Twelve pit bull terrier-type dogs with JOGD and 12 age-matched healthy pit bull terrier-type dogs. OBJECTIVE: To investigate immunological differences between age-matched healthy and JOGD pit bull terrier-type dogs by flow cytometry, multiplex, molecular and serological assays. METHODS AND MATERIALS: Flow cytometry quantified B cells expressing MHCII or surface-bound IgG, CD4+ T cells expressing MHCII, CD8 T cells expressing MHCII or CD11a, neutrophil and monocyte markers. Surface expression was quantified by calculating the geometric mean fluorescence index. The Wilcoxon rank sum test was used to compare median results for IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, IL-13, IL-18, FOXP3, monocyte chemoattractant protein-1, GM-CSF, KC, IgE, IgA, IgG, IgM, C-reactive protein, lymphocyte, neutrophil and monocyte in the groups. IFN-gamma, IP-10, IL-15, IL-31 and TNF-alpha also were measured; however, insufficient dogs (<5) had values that were in range of the assay to allow for statistical evaluation. Significance was defined as P < 0.05. RESULTS: Serum concentrations of IL-2, IL-18 and MCP-1 were significantly higher (P = 0.01, P = 0.01, P = 0.04) in the JOGD group. Also, IgA median value was significantly higher (P = 0.002) in pit bull terrier-type dogs with JOGD. Flow cytometry revealed that T-cell, neutrophil and monocyte markers were not different between groups. CONCLUSIONS: Results suggest an appropriate compensatory immune response by pit bull terrier-type dogs in the JOGD group and do not support the explanation of global immune deficiency in these dogs.

Can immunosuppressive therapy facilitate the diagnosis and affect the clinical signs of canine scabies? A retrospective study of 79 cases.

BACKGROUND: Scabies infestation is one of the most pruritic dermatoses of dogs. It is often misdiagnosed and dogs are treated with immunomodulatory drugs (IMD) to relieve pruritus. HYPOTHESIS/OBJECTIVES: The primary goals of this study were to determine the impact of IMD on skin scraping results, pruritus level and extent of skin lesions, and to evaluate whether disease duration is associated with positive skin scrapings and contagion. ANIMALS: Seventy nine dogs with a final diagnosis of scabies. METHODS: Inclusion in this retrospective study required a positive skin scraping for scabies or a clinical response to an acaricidal treatment trial. RESULTS: The average pruritus score of dogs that received IMD (8.71) was significantly higher than those that did not (7.43; P = 0.03). However, there were no significant differences in either the rates of positive skin scrapings (79.6% versus 59.1%; P = 0.13) or the mean number of body sites affected (3.8 versus 3.4; P = 0.30) between dogs that received IMD and those that did not. Neither skin scraping status nor duration of clinical signs were correlated with a report of contagion within the household. CONCLUSION/CLINICAL IMPORTANCE: IMD was associated with a significant increase in the pruritus level, but not with the mean number of lesional body sites. Dogs exposed to IMD had a 20.5% higher rate of positive skin scrapings. This difference could be clinically relevant and lack of statistical significance may indicate an underpowered study.

Dermatophytosis is uncommon in asymptomatic wild eastern cottontail rabbits in Illinois, Midwestern United States.

OBJECTIVE: To investigate the presence of dermatophytes on the haircoat of wild eastern cottontail rabbits (ECR) (Sylvilagus floridanus) with and without skin lesions. ANIMALS: 2-week-old or older ECR admitted to a Wildlife Medical Clinic (WMC) in central Illinois, Midwest United States, from September 2021 to August 2022. METHODS: ECR were surveyed over a 1-year period to assess the prevalence and seasonality of dermatophytosis. A Wood's lamp exam was performed over the haircoat. Hairs were sampled with a sterile toothbrush and plated on Sabouraud dextrose agar. The plates were photographed twice weekly for 3 weeks, and colonies were identified as contaminants or dermatophytes. RESULTS: 523 ECR were admitted to WMC, 141 ECR met the age inclusion criteria, and 121 samples were plated. ECR presented as a litter were sampled together. None of the sampled ECR presented skin lesions other than acute traumatic wounds. No fluorescence was observed on any ECR during the Wood's lamp examination. Based on culture colony morphology, 115/121 of the samples were identified as contaminants and no growth was observed in 6/121 of plates. Dermatophytes' colonies were not identified on any of the culture plates. CLINICAL RELEVANCE: Dermatophytes are zoonotic fungi and can potentially be carried by wild animals. The fungal infection poses a health concern to humans and domestic pets through direct interaction. Our current results suggest that dermatophytosis may not be prevalent in asymptomatic wild rabbits in the studied areas of the Midwestern United States.

Effectiveness of sarolaner in the clinical management of furuncular myiasis in dogs naturally infested with Dermatobia hominis (Diptera: Cuterebridae).

BACKGROUND: The human botfly, Dermatobia hominis, is a common cause of furuncular myiasis in dogs in Latin America. Lesions can be single or multiple, each harboring an individual larva, presented as an erythematous nodule that causes pruritus and pain. Typical treatment consists of sedation for removal of larvae by surgical incision or manual pressure. Medications to kill the larva before its extraction can reduce inflammation and discomfort and provide a less traumatic larval removal. Isoxazolines are broad-spectrum ectoparasiticides with larvicidal activity previously reported in the treatment of screwworm myiasis in companion animals. The aim of this study was to evaluate the effectiveness of sarolaner as part of the clinical management of furuncular myiasis in dogs caused by D. hominis larvae. METHODS: Ten short-haired mixed breed dogs naturally infested with D. hominis were enrolled. Clinical diagnosis was achieved by observation of skin nodules and visualization of larval motility through the lesion orifice. Sarolaner was administered at manufacturer recommended dose for fleas and ticks. Lesions were reexamined 24 h post-treatment and assessed for viability of larvae. Larvae were removed by digital compression and identified as D. hominis. RESULTS: Seventy-five D. hominis larvae were retrieved from ten dogs. No live larvae were observed, demonstrating 100% larvicidal efficacy of sarolaner. Skin lesions were healed 30 days post-treatment and new lesions were not observed. CONCLUSIONS: Sarolaner seems to be effective as larvicidal treatment for dogs with furuncular myiasis, reducing discomfort caused by the presence of the larva in the skin and facilitating its safe removal.

Salivary proteomics of healthy dogs: An in depth catalog.

OBJECTIVE: To provide an in-depth catalog of the salivary proteome and endogenous peptidome of healthy dogs, evaluate proteins and peptides with antimicrobial properties, and compare the most common salivary proteins and peptides between different breed phylogeny groups. METHODS: 36 healthy dogs without evidence of periodontal disease representing four breed phylogeny groups, based upon single nucleotide polymorphism haplotypes (ancient, herding/sighthound, and two miscellaneous groups). Saliva collected from dogs was pooled by phylogeny group and analyzed using nanoscale liquid chromatography-tandem mass spectrometry. Resulting tandem mass spectra were compared to databases for identification of endogenous peptides and inferred proteins. RESULTS: 2,491 proteins and endogenous peptides were found in the saliva of healthy dogs with no periodontal disease. All dog phylogeny groups' saliva was rich in proteins and peptides with antimicrobial functions. The ancient breeds group was distinct in that it contained unique proteins and was missing many proteins and peptides present in the other groups. CONCLUSIONS AND CLINICAL RELEVANCE: Using a sophisticated nanoscale liquid chromatography-tandem mass spectrometry, we were able to identify 10-fold more salivary proteins than previously reported in dogs. Seven of the top 10 most abundant proteins or peptides serve immune functions and many more with various antimicrobial mechanisms were found. This is the most comprehensive analysis of healthy canine saliva to date, and will provide the groundwork for future studies analyzing salivary proteins and endogenous peptides in disease states.

Myiasis caused by the New World screwworm fly Cochliomyia hominivorax (Diptera: Calliphoridae) in cats from Brazil: report of five cases.

This paper reports five cases of intact adult male crossbreed cats presenting with myiasis caused by Cochliomyia hominivorax. Three were stray animals that died despite treatment due to the severity of lesions while two were client-owned cats previously treated with cryosurgery which completely recovered. Myiasis caused by the New World screwworm fly in cats appears to be more frequent than previously thought, deserving more attention from both veterinary practitioners and owners.

Furuncular myiasis caused by the human bot-fly Dermatobia hominis in a domestic cat from Brazil.

This paper reports a case of furuncular myiasis caused by the human bot-fly Dermatobia hominis in a domestic cat from Brazil. A crossbred shorthaired female cat of approximately 3 years old, presented with three boil-like cutaneous lesions at the left cranioventral region of the neck. These were diagnosed as furuncular myiasis. The animal was sedated, and after shaving the fur, bot-fly larvae were removed from the lesion by digital compression. Afterwards, the wounds were treated with 10% iodine solution and also with wound-healing cream containing sulfanilamide, urea and beeswax. Maggots were identified as third-stage larvae of D hominis. Clinical case reports of human bot-fly myiasis in cats are relevant due to its scarce occurrence in feline veterinary practice in some countries.

Larvicidal efficacy of nitenpyram on the treatment of myiasis caused by Cochliomyia hominivorax (Diptera: Calliphoridae) in dogs.

The purpose of our study was to evaluate the larvicidal efficacy of nitenpyram for the treatment of screwworm myiasis caused by Cochliomyia hominivorax in naturally infested dogs. Seven Beagle dogs presenting with myiasis were treated with nitenpyram twice at an interval of 6 h. The animals received dosages between 1.43 and 4.42 mg/kg body weight of nitenpyram in each given treatment. The criteria used to determine the drug efficacy were larval expulsion and fall. These were quantified at 15 min intervals within the first hour followed by 2, 3, 4, 6, and 18 h post-treatment. The highest larval expulsion happened between 1 and 2 h post-treatment. The spontaneous larval expulsion percentages were 86% and 94.11% for 6 and 18 h after the first treatment, respectively. Larvae were expelled until 18 h post-treatment. After this period the remaining dead larvae were mechanically removed. Nitenpyram showed 100% efficacy on the treatment of myiasis by C. hominivorax in naturally infested dogs.

Clinical and parasitological evaluation of pour-on fluazuron and ivermectin for treating canine demodicosis / Avaliação clínica e parasitológica do fluazuron e da ivermectina pour-on no tratamento da demodiciose canina

The objective of the study was to evaluate the efficacy of pour-on formulations of fluazuron and ivermectin in different therapeutic protocols for treatment of demodicosis by means of quantifying mites with skin scraping, histological and clinical evaluation in dogs. Eighteen dogs with skin scrapings positive for Demodex canis were evaluated, divided into three groups. All the animals were treated every 14 days, completing 6 treatments for each animal (days 0, 14, 28, 42, 56 and 70). In group 1, pour-on 2.5% fluazuron was used at the dose of 20mg/kg; in the group 2 pour-on 2.5% fluazuron at a dose of 20 mg/kg in association with pour-on 0.5% ivermectin at the dose of 0.6mg/kg; and in group 3, pour-on 0.5% ivermectin alone was used, at the dose of 0.6mg/kg. The treatment was evaluated and monitored through skin scrapings and clinical follow-up of the lesions every 14 days for 84 days, and through histopathological examination at the end of each treatment protocol. The success rate was defined as the percentage of dogs in each group that had negative skin scrapings after the treatment: this was 16.67% for group 1, and 50% for groups 2 and 3. The reduction in mite counts reached effectiveness of 67.66%, 88.99% and 84.29% for groups 1, 2 and 3 respectively. The Wilcoxon test showed that there was a significant difference between the number of mites before and after treatment in groups 2 and 3. The histopathological examination revealed that only group 1 showed no significant difference in the intensity of infestation between days 0 and 84. Clinically, there was no significant difference between the evaluation before and after treatment in the three groups. pour-on 2.5% fluazuron and pour-on 0.5% ivermectin were not effective for treating canine demodicosis, either in association or as single therapy, when applied every 14 days for a period of 70 days. Quantification of mites using skin scrapings and histological evaluation proved to be ineffective, either one as sole therapeutic evaluation parameters, for canine demodicosis.(AU)

O objetivo do presente estudo foi avaliar a eficácia do fluazuron e da ivermectina pour-on em diferentes protocolos terapêuticos no tratamento da demodiciose, através da quantificação de ácaros por raspados cutâneos e exames histológicos, além da avaliação dos cães. Foram avaliados 18 cães com raspados cutâneos positivos para o ácaro Demodex canis, divididos em três grupos. Todos os animais foram tratados a cada 14 dias, totalizando seis tratamentos em cada cão (Dias 0, 14, 28, 42, 56 e 70). No grupo 1 foi utilizado fluazuron 2,5% pour-on na dosagem de 20mg/kg; no grupo 2 foi empregado fluazuron 2,5% pour-on na dosagem de 20mg/kg associado a ivermectina 0,5% pour-on, na dosagem de 0,6mg/kg e, no grupo 3, somente ivermectina 0,5% pour-on 0,6mg/kg. Raspados cutâneos e acompanhamento clínico das lesões foram realizados a cada 14 dias por 84 dias e realizado exame histopatológico ao final de cada protocolo terapêutico. A taxa de sucesso foi definida pela porcentagem de cães em cada grupo com raspados negativos ao final do tratamento, que foi 16,67% para o grupo 1 e 50% para os grupos 2 e 3. A redução na contagem no número de ácaros alcançou eficácia de até 67,66%; 88,99% e 84,29%, nos grupos 1, 2 e 3, respectivamente. O teste de Wilcoxon mostrou que houve diferença significativa entre a quantidade de ácaros antes e após o tratamento nos grupos 2 e 3. No exame histopatológico apenas o grupo 1 não apresentou diferença significativa na intensidade da infestação entre os dias 0 e 84. Clinicamente não houve diferença significativa entre as avaliações antes e após o tratamento dos três grupos. O fluazuron 2,5% pour-on e a ivermectina 0,5% pour-on associados ou como terapia única, não foram eficazes no tratamento da demodiciose canina, quando aplicados a cada 14 dias em um período de 70 dias. A quantificação de ácaros através do exame parasitológico em raspado cutâneo e em exame histopatológico demonstrou-se ineficaz como parâmetro isolado de avaliação pós-terapêutica para demodiciose canina.(AU)

[Efficacy of eprinomectin in the control of Haematobia irritans in cattle]. / Eficácia mosquicida da eprinomectina no controlede Haematobia irritans em bovinos

To evaluate the efficacy of a formulation with 0,5% of eprinomectin in cattle to control H. irritans, two trials were conducted for the control of H. irritans in the field in the state of Rio de Janeiro, using 0,5% of eprinomectin, at a dose rate of 500 mc g/kg body weight, corresponding to 10 mL/100 kg. The efficacies for days +7, +14, +21 e +28 after treatment were respectively 100%; 94,3%; 86,2% and 24,5% for the first study and 100%, 100%, 100%, and 0% for the second one.

[Miticidal efficacy of thiabendazole against Otodectes cynotis (Hering, 1838) in dogs]. / Eficácia acaricida do tiabendazol sobre Otodectes cynotis (Hering, 1838) em cães.

The aim of the present study was to evaluate the efficacy of thiabendazole on the treatment of Otodectes cynotis infestations in dogs. Ten naturally infested beagle dogs were used. The mites were diagnosed through otoscopy. Dogs were examined three days before treatment (day -3) and on the treatment day (day 0). They were randomly divided into two groups, five animals for the control group and five for the treated. During seven days, was applied in both ears of the treated dogs 1ml of the thiabendazole 5% solution, which correspond to 50mg of the product. All animals were reexamined through otoscopy on days +1, +3, +7, +10, +17, +24 and +31. The dogs on the control group showed mites in both ears during the whole period of observation. On the treated group the efficacy varied from 20% on the left ear to 80% on the right ear, on the first day after treatment. On days +3, +7, +10, +17, +24 and +31 the medium efficacy was 100% on both ears. The thiabendazole was efficient on the elimination of O. cynotis in dogs when used on the dose of 50mg per ear during seven following days.

Factors associated with the prevalence of Otodectes cynotis in an ambulatory population of dogs / Fatores associados à prevalência da infestação por Otodectes cynotis em uma população ambulatorial

The objective was to evaluate the factors associated with the prevalence of Otodectes cynotis infestations in dogs assisted at the Dermatology Service of the Veterinary Hospital, Universidade Federal Rural do Rio de Janeiro. A total of 250 dogs were examined through direct smear of ear samples using a stereoscopic microscope, for the parasitological diagnostic. All dog owners were interviewed and data regarding the animals and their environments were individually recorded. Mite infestation was observed in 15 animals, with a prevalence of 6 percent. The variables were tested regarding their association with the mites, using the χ2 test and, when appropriate, the Fisher exact test. There were no evidences that age (p = 0,20), sex (p = 0,31), breed (p = 0,50), shape of ear (p = 0,66), type (p = 0,19) and length of hair (p = 0,14) and contact with other animals (p = 0,06) could act as potential risk factors for O. cynotis infestation. However, living environment (p = 0,03) and frequency of environmental cleaning (p = 0,005) may facilitate the infestation. The occurrence of pruritus was associated to the presence of mites (p<0,001), suggesting to be an effect of the parasitism.

O objetivo deste estudo foi avaliar os fatores associados à prevalência da infestação por Otodectes cynotis em cães atendidos no Setor de Dermatologia do Hospital Veterinário de Pequenos Animais, Universidade Federal Rural do Rio de Janeiro. Foram atendidos 250 cães, sendo o diagnóstico feito através de visualização do ácaro, presente no cerumem coletado e examinado sob microscopia esterioscópica. Todos os proprietários dos cães foram entrevistados para preenchimento de fichas individuais com dados dos animais e do ambiente em que estes viviam. A infestação por O. cynotis foi observada em 15 animais, sendo a prevalência de 6 por cento. A associação entre as variáveis e a presença dos ácaros foi testada através do χ2 e quando pertinente pelo teste de Fisher exato. Não houve evidências que permitissem concluir que a idade (p = 0,20), o sexo (p = 0,31), a raça (p = 0,50), o formato das orelhas (p = 0,66), o tipo (p = 0,19) e comprimento da pelagem (p = 0,14) e, o convívio com outros animais (p = 0,06) poderiam atuar como possíveis fatores de risco para a infestação. Entretanto, o ambiente em que viviam os animais (p = 0,03) e a freqüência de limpeza (p = 0,005) parecem propiciar a infestação. A ocorrência de prurido esteve associada à presença dos ácaros (p<0,001), sugerindo ser um efeito do parasitismo.